BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 16648484)

  • 1. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
    Wang GG; Pasillas MP; Kamps MP
    Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
    Wang GG; Pasillas MP; Kamps MP
    Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.
    Knoepfler PS; Calvo KR; Chen H; Antonarakis SE; Kamps MP
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14553-8. PubMed ID: 9405651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells.
    Shen WF; Rozenfeld S; Kwong A; Köm ves LG; Lawrence HJ; Largman C
    Mol Cell Biol; 1999 Apr; 19(4):3051-61. PubMed ID: 10082572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis.
    Schnabel CA; Jacobs Y; Cleary ML
    Oncogene; 2000 Feb; 19(5):608-16. PubMed ID: 10698505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.
    Calvo KR; Sykes DB; Pasillas M; Kamps MP
    Mol Cell Biol; 2000 May; 20(9):3274-85. PubMed ID: 10757811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1.
    Knoepfler PS; Bergstrom DA; Uetsuki T; Dac-Korytko I; Sun YH; Wright WE; Tapscott SJ; Kamps MP
    Nucleic Acids Res; 1999 Sep; 27(18):3752-61. PubMed ID: 10471746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
    Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR; Knoepfler P; McGrath S; Kamps MP
    Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.
    Garcia-Cuellar MP; Steger J; Füller E; Hetzner K; Slany RK
    Haematologica; 2015 Jul; 100(7):905-13. PubMed ID: 25911551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.
    Chang CP; Jacobs Y; Nakamura T; Jenkins NA; Copeland NG; Cleary ML
    Mol Cell Biol; 1997 Oct; 17(10):5679-87. PubMed ID: 9315626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.
    Argiropoulos B; Yung E; Xiang P; Lo CY; Kuchenbauer F; Palmqvist L; Reindl C; Heuser M; Sekulovic S; Rosten P; Muranyi A; Goh SL; Featherstone M; Humphries RK
    Blood; 2010 May; 115(20):4071-82. PubMed ID: 20237320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEIS C termini harbor transcriptional activation domains that respond to cell signaling.
    Huang H; Rastegar M; Bodner C; Goh SL; Rambaldi I; Featherstone M
    J Biol Chem; 2005 Mar; 280(11):10119-27. PubMed ID: 15654074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia.
    Thorsteinsdottir U; Kroon E; Jerome L; Blasi F; Sauvageau G
    Mol Cell Biol; 2001 Jan; 21(1):224-34. PubMed ID: 11113197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
    Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
    Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimeric association of Hox and TALE homeodomain proteins mediates Hoxb2 hindbrain enhancer activity.
    Jacobs Y; Schnabel CA; Cleary ML
    Mol Cell Biol; 1999 Jul; 19(7):5134-42. PubMed ID: 10373562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation.
    Morgado E; Albouhair S; Lavau C
    Blood; 2007 May; 109(9):4020-2. PubMed ID: 17202314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein.
    Bisaillon R; Wilhelm BT; Krosl J; Sauvageau G
    Blood; 2011 Oct; 118(17):4682-9. PubMed ID: 21900201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias.
    Lawrence HJ; Rozenfeld S; Cruz C; Matsukuma K; Kwong A; Kömüves L; Buchberg AM; Largman C
    Leukemia; 1999 Dec; 13(12):1993-9. PubMed ID: 10602420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.